Forian Inc. (FORA)
NASDAQ: FORA · Real-Time Price · USD
2.145
-0.035 (-1.61%)
At close: Dec 5, 2025, 4:00 PM EST
2.130
-0.015 (-0.69%)
After-hours: Dec 5, 2025, 4:45 PM EST
Company Description
Forian Inc. provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the life science, healthcare, and financial services industries.
It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.
The company’s subscription and services-based solutions cover the life sciences, pharmaceutical services, healthcare payer, and provider and financial services industries.
Forian Inc. was founded in 2020 and is headquartered in Newtown, Pennsylvania.
Forian Inc.
| Country | United States |
| Founded | 2014 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 48 |
| CEO | Max Wygod |
Contact Details
Address: 41 University Drive, Suite 400 Newtown, Pennsylvania 18940 United States | |
| Phone | 267 225 6263 |
| Website | forian.com |
Stock Details
| Ticker Symbol | FORA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001829280 |
| CUSIP Number | 34630N106 |
| ISIN Number | US34630N1063 |
| Employer ID | 85-3467693 |
| SIC Code | 7374 |
Key Executives
| Name | Position |
|---|---|
| Max C. Wygod | Co-Founder, Chief Executive Officer, President and Executive Chairman of the Board |
| Michael Vesey CPA | Chief Financial Officer |
| Adam H. Dublin | Co-Founder, Chief Strategy Officer and Director |
| Caroline Strickland Mcgrail | General Counsel |
| Jason Holden | Vice President of Corporate Development |
| Paul Reuscher | Chief Commercial Officer |
| Jeff Forringer | President of Kyber Data Science |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 4, 2025 | PRE 14A | Other preliminary proxy statements |
| Nov 14, 2025 | 10-Q | Quarterly Report |
| Nov 14, 2025 | 8-K | Current Report |
| Oct 3, 2025 | SCHEDULE 13D/A | Filing |
| Oct 2, 2025 | SCHEDULE 13D/A | Filing |
| Aug 25, 2025 | SCHEDULE 13D | Filing |
| Aug 25, 2025 | SCHEDULE 13D/A | Filing |
| Aug 25, 2025 | 8-K | Current Report |
| Aug 20, 2025 | 8-K | Current Report |
| Aug 15, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |